Advertisement

Topics

More positive reimbursement news for Erbitux in the UK

09:56 EDT 8 Aug 2017 | thePharmaLetter

The UK’s health technology assessor has provided Germany’s Merck KGaA with a positive reimbursement

Original Article: More positive reimbursement news for Erbitux in the UK

NEXT ARTICLE

More From BioPortfolio on "More positive reimbursement news for Erbitux in the UK"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...